189 related articles for article (PubMed ID: 10394556)
1. Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases.
Raskin KS; Dachauer JD; Doeden AL; Rayburn WF
J Reprod Med; 1999 Jun; 44(6):571-4. PubMed ID: 10394556
[TBL] [Abstract][Full Text] [Related]
2. Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections.
Taylor DR; Doughty AS; Kaufman H; Yang L; Iannucci TA
J Reprod Med; 2002 Jul; 47(7):549-54. PubMed ID: 12170531
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 for cervical ripening: a multicenter study of patients with prior cesarean delivery.
Flamm BL; Anton D; Goings JR; Newman J
Am J Perinatol; 1997 Mar; 14(3):157-60. PubMed ID: 9259919
[TBL] [Abstract][Full Text] [Related]
4. Vaginal birth after cesarean section: risk of uterine rupture with labor induction.
Ouzounian JG; Miller DA; Hiebert CJ; Battista LR; Lee RH
Am J Perinatol; 2011 Sep; 28(8):593-6. PubMed ID: 21424988
[TBL] [Abstract][Full Text] [Related]
5. Posterior uterine rupture in a woman with a previous Cesarean delivery.
Figueroa R; Garry D; Mackenzie AP
J Matern Fetal Neonatal Med; 2003 Aug; 14(2):130-1. PubMed ID: 14629095
[TBL] [Abstract][Full Text] [Related]
6. Obstetric outcomes after cervical ripening by multiple doses of vaginal prostaglandin E2.
Chan LY; Fu L; Leung TN; Wong SF; Lau TK
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):70-4. PubMed ID: 14678088
[TBL] [Abstract][Full Text] [Related]
7. Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix.
Yogev Y; Ben-Haroush A; Lahav E; Horowitz E; Hod M; Kaplan B
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):173-6. PubMed ID: 15358459
[TBL] [Abstract][Full Text] [Related]
8. Cervical ripening by prostaglandin E2 in patients with a previous cesarean section.
Bouchghoul H; Zeino S; Houllier M; Senat MV
J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101699. PubMed ID: 32018044
[TBL] [Abstract][Full Text] [Related]
9. Trial of labor and vaginal birth after cesarean section in patients with uterine Müllerian anomalies: a population-based study.
Erez O; Dukler D; Novack L; Rozen A; Zolotnik L; Bashiri A; Koifman A; Mazor M
Am J Obstet Gynecol; 2007 Jun; 196(6):537.e1-11. PubMed ID: 17547885
[TBL] [Abstract][Full Text] [Related]
10. Rupture of the scarred uterus.
Grossetti E; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
Acta Obstet Gynecol Scand; 2007; 86(5):572-8. PubMed ID: 17464586
[TBL] [Abstract][Full Text] [Related]
11. Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery.
Landon MB; Spong CY; Thom E; Hauth JC; Bloom SL; Varner MW; Moawad AH; Caritis SN; Harper M; Wapner RJ; Sorokin Y; Miodovnik M; Carpenter M; Peaceman AM; O'sullivan MJ; Sibai BM; Langer O; Thorp JM; Ramin SM; Mercer BM; Gabbe SG;
Obstet Gynecol; 2006 Jul; 108(1):12-20. PubMed ID: 16816050
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
[TBL] [Abstract][Full Text] [Related]
13. Abruptio placentae associated with misoprostol use in women with preeclampsia.
Fontenot MT; Lewis DF; Barton CB; Jones EM; Moore JA; Evans AT
J Reprod Med; 2005 Sep; 50(9):653-8. PubMed ID: 16363752
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
Rabl M; Joura EA; Yücel Y; Egarter C
J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
[TBL] [Abstract][Full Text] [Related]
15. Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening.
Hill DA; Chez RA; Quinlan J; Fuentes A; LaCombe J
J Reprod Med; 2000 Oct; 45(10):823-6. PubMed ID: 11077631
[TBL] [Abstract][Full Text] [Related]
16. Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital.
Blair FC; Tassone SA; Pearman CR; St Cyr MB; Rayburn WF
J Reprod Med; 1998 May; 43(5):408-12. PubMed ID: 9610462
[TBL] [Abstract][Full Text] [Related]
17. [Uterine rupture without predisposing factors after a single vaginal PgE2 administration in prolonged pregnancy].
Zieger W; Leveringhaus A; Wischnik A; Melchert F
Zentralbl Gynakol; 1995; 117(1):51-3. PubMed ID: 7879464
[TBL] [Abstract][Full Text] [Related]
18. Safety of low-dose prostaglandin E2 induction in grandmultiparous women with previous cesarean delivery.
Haas J; Barzilay E; Chayen B; Lebovitz O; Yinon Y; Mazaki-Tovi S; Harel L
J Matern Fetal Neonatal Med; 2014 Mar; 27(5):445-8. PubMed ID: 23841832
[TBL] [Abstract][Full Text] [Related]
19. SOGC clinical practice guidelines. Guidelines for vaginal birth after previous caesarean birth. Number 155 (Replaces guideline Number 147), February 2005.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):319-31. PubMed ID: 16001462
[TBL] [Abstract][Full Text] [Related]
20. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2.
Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M
Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
